Ryan Driscoll
Known title: VP, General Counsel, SecretaryCIK: 0001479936
Associated companies
Transaction History
| TER | ▼ Sell | Open Market | 680 | $257K | 5/7/2026 | View on chart |
| TER | ▲ Buy | Grant | 1,784 | $0 | 2/4/2026 | View on chart |
| TER | ▼ Sell | Tax Withholding | 414 | $103K | 2/2/2026 | View on chart |
| TER | ▼ Sell | Tax Withholding | 82 | $21K | 1/28/2026 | View on chart |
| TER | ▼ Sell | Tax Withholding | 113 | $27K | 1/27/2026 | View on chart |
| TER | ▼ Sell | Open Market | 216 | $24K | 2/4/2025 | View on chart |
| TER | ▼ Sell | Tax Withholding | 199 | $22K | 2/3/2025 | View on chart |
| TER | ▲ Buy | Grant | 3,110 | $0 | 1/31/2025 | View on chart |
| TER | ▼ Sell | Open Market | 437 | $45K | 1/30/2025 | View on chart |
| TER | ▼ Sell | Tax Withholding | 77 | $9K | 1/29/2025 | View on chart |
| TER | ▼ Sell | Open Market | 76 | $9K | 1/29/2025 | View on chart |
| TER | ▼ Sell | Tax Withholding | 82 | $10K | 1/28/2025 | View on chart |
| TER | ▼ Sell | Open Market | 107 | $13K | 1/28/2025 | View on chart |
| TER | ▼ Sell | Tax Withholding | 114 | $14K | 1/27/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Teradyne (TER) Shares Fall, Fundamentals Show Growth
Recent articles note that TER's stock has fallen more sharply than the broader market and is listed among the worst‑performing chip stocks this week. At the same time, other coverage highlights earnings revisions and a surge in sales that point to strong growth fundamentals. The price action occurs while the RSI is near the low‑30s and the stock is testing a support level around $364. Analysts maintain an average target near $446, suggesting expectations of recovery.
Teradyne (TER) Shares Fall, Fundamentals Show Growth. Recent articles note that TER's stock has fallen more sharply than the broader market and is listed among the worst‑performing chip stocks this week. At the same time, other coverage highlights earnings revisions and a surge in sales that point to strong growth fundamentals. The price action occurs while the RSI is near the low‑30s and the stock is testing a support level around $364. Analysts maintain an average target near $446, suggesting expectations of recovery.